VT-1598

CAT:
804-HY-123777-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
VT-1598 - image 1

VT-1598

  • UNSPSC Description:

    VT-1598 is an orally active and selective fungal inhibitor targeting CYP51. VT-1598 shows anti-fungal activity against Candida auris[1][2]. VT-1598 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • Target Antigen:

    Fungal
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Field of Research:

    Infection; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/vt-1598.html
  • Purity:

    99.96
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    N#CC1=CC=C(COC2=CC=C(C#CC3=CC=C(C(F)(F)[C@@](O)(C4=CC=C(F)C=C4F)CN5N=NN=C5)N=C3)C=C2)C=C1
  • Molecular Weight:

    584.52
  • References & Citations:

    [1]Nathan P Wiederhold, et al. The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02233-18.|[2]Timothy J Break, et al. VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice. J Antimicrob Chemother. 2018 Aug 1;73(8):2089-2094.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    Phase 1
  • CAS Number:

    2089320-99-8